AlzClub News by Alexei Koudinov, MD, PhD, DrSci

There is a kind of magic in my awaking at 5AM this Sunday, 15 August 2010. After having morning physical excersises and breakfast and logged in to make a new life of my http://www.alzclub.org web site. Previously (since 2004 I beleive), it look as this archieved copy at my koudinov.info/alzclub web folder.

For years I was (and still I am) confident, that Alzheiemr's is such a corrupted research field, that you one can take an academic leave for three, five, or even ten years, and then come back exactly to the date he or she left. Those bastards and mafia-like strucrure of academic science and hidden big pharmaceutical bucks behind them leaves no space for an open minded innovative ideas. Don't ask how it is possible, it is the way Alzheimer's research exists.

So, I decided to remove digital dyst out of my advocacy, scientific and lay language writings and make it public here, so, you, dear reader, while have original content from the author, directly and with no "dealers", like poor and often corrupted academic journals.

It was no surprise that three days later Eli Lilly announced the halt of Alheimer's therapy trial, as patients worsen on a chemical called secretase inhibitor, which is an anti-amyloid beta therapy based on ill-fated and poor-minded (yet commercially, not public succesful) amyloid hypothesis (read dogma) of Alzheimer's disease.

Today, by the end of the day August 19, I decided to start another theme web site, devoted exclusively to reprinting Alzheimer's news and press releases from different sources. I thus would like to separate my original content from content by others. I will still announce interesting news at major AlzClub.org web site while providing brief summary. All other web sites, including Alzheimer's History, Alzheimer's Amyloid beta courses for Public and Professionals, Alzheimer's Code and other emerging projects will syndicating the content of each other, so, every new material will be visible, and just click away.

Surely, all the projects are non-profit, public and ad supported: while I do not expect to make revenue, it will be nice to have advertisement support cover my publishing and associated expenses.

Remaining independent and truly yours,

Alexei Koudinov, MD, PhD, DrSci

neuroscientist, Alzheimer's researcher

a man of 44 who loves this world

P.S. First annotated by me news item to follow in just 10 minutes or so, with Press release of Alzheimer's Association on Eli Lilly Alzheimer's clinical trial termination